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Telomeres are important for maintaining genomic stability. Telomere length has been
associated with aging, disease, and mortality and is highly heritable (∼82%). In this
study, we aimed to identify rare genetic variants associated with telomere length
using whole-exome sequence data. We studied 1,303 participants of the Erasmus
Rucphen Family (ERF) study, 1,259 of the Rotterdam Study (RS), and 674 of the
British Heart Foundation Family Heart Study (BHF-FHS). We conducted two analyses,
first we analyzed the family-based ERF study and used the RS and BHF-FHS for
replication. Second, we combined the summary data of the three studies in a meta-
analysis. Telomere length was measured by quantitative polymerase chain reaction in
blood. We identified nine rare variants significantly associated with telomere length
(p-value < 1.42 × 10−7, minor allele frequency of 0.2–0.5%) in the ERF study. Eight
of these variants (in C11orf65, ACAT1, NPAT, ATM, KDELC2, and EXPH5) were
located on chromosome 11q22.3 that contains ATM, a gene involved in telomere
maintenance. Although we were unable to replicate the variants in the RS and BHF-
FHS (p-value ≥ 0.21), segregation analysis showed that all variants segregate with
shorter telomere length in a family. In the meta-analysis of all studies, a nominally
significant association with LTL was observed with a rare variant in RPL8 (p-
value = 1.48 × 10−6), which has previously been associated with age. Additionally, a
novel rare variant in the known RTEL1 locus showed suggestive evidence for association
(p-value = 1.18 × 10−4) with LTL. To conclude, we identified novel rare variants
associated with telomere length. Larger samples size are needed to confirm these
findings and to identify additional variants.
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INTRODUCTION
Telomeres are DNA structures located at the ends of
chromosomes and consist of tandem hexanucleotide sequence
repeats (TTAGGG) (Blackburn and Gall, 1978). They are
important for maintaining genomic stability by preventing
DNA degradation and chromosomal fusions (Blackburn, 2000).
Telomeres are shortened with each cell division due to the
inability of DNA polymerase to fully extend the 3′ end of the
DNA strand during replication. When the telomeres reach a
critical length, this leads to cellular senescence and ultimately
to cell death, making them regulators of the replicative capacity
of a cell and markers of biological age (Lindsey et al., 1991;
Allsopp et al., 1992).
Shorter leukocyte telomere length (LTL) has been associated
with several age-related diseases including cardiovascular
diseases (Brouilette et al., 2003, 2007; Benetos et al., 2004;
Fitzpatrick et al., 2007; Willeit et al., 2010a; Haycock et al., 2014),
cancer (Hastie et al., 1990; Willeit et al., 2010b, 2011; Bojesen
et al., 2013) and dementia (Martin-Ruiz et al., 2006; Grodstein
et al., 2008; Honig et al., 2012). LTL has also been associated with
mortality (Cawthon et al., 2003; Kimura et al., 2008; Fitzpatrick
et al., 2011; Honig et al., 2012; Deelen et al., 2014; Rode et al.,
2015; Marioni et al., 2016). However, this association has been
inconsistent (Martin-Ruiz et al., 2005; Harris et al., 2006; Njajou
et al., 2009; Houben et al., 2011; Strandberg et al., 2011; Needham
et al., 2015). LTL is highly heritable with heritability estimates
ranging from 34 to 82% (Slagboom et al., 1994; Bischoff et al.,
2005; Vasa-Nicotera et al., 2005; Andrew et al., 2006; Broer et al.,
2013). Previously, genome-wide association studies (GWASs)
in European ancestry studies have identified common variants
associated with LTL located in multiple genes, including: TERC
(Codd et al., 2010, 2013; Mangino et al., 2012; Pooley et al.,
2013), TERT (Codd et al., 2013; Pooley et al., 2013), NAF1 (Codd
et al., 2013), OBFC1 (Levy et al., 2010; Mangino et al., 2012;
Codd et al., 2013; Pooley et al., 2013), RTEL1 (Codd et al., 2013),
CTC1 (Mangino et al., 2012), ZNF676 (Mangino et al., 2012),
ZNF208 (Codd et al., 2013), ACYP2 (Codd et al., 2013), DCAF4
(Mangino et al., 2015), and PXK (Pooley et al., 2013). However,
these variants explain< 5% of the heritability.
Up until now, no systemic whole exome or genome screen
for rare variants has been published, despite the fact that
these may explain part of the heritability (Manolio et al.,
2009). Rare variants are not well captured by microarrays used
for GWAS and remain difficult to impute, despite the recent
improvements in imputation panels (McCarthy et al., 2016).
Next generation sequencing technologies, such as whole-exome
sequencing (WES), are better suited to study rare variants. In this
study, we present a dual analysis. First, we conducted a genome-
wide WES analysis of LTL in 1,303 individuals of the Dutch
Erasmus Rucphen Family (ERF) study to search for rare genetic
variants associated with LTL. The advantage of a family-based
study is that the segregation of rare variants can be studied. We
performed a replication analysis in the Rotterdam Study (RS) and
the British Heart Foundation Family Heart Study (BHF-FHS).
Next, we pooled the data together and conducted a meta-analysis
of the association results of all three cohorts.
RESULTS
Descriptive statistics of the family-based and population-based
studies are provided in Table 1. Mean age at LTL measurement
was 49 years (SD = 15.0) in the ERF study and 61% of the
study participants were female. The RS participants were older
(x¯age = 75 years, SD = 7.7) and 57% of the participants were
female, while mean age in the BHF-FHS was 58 years (SD = 8.2)
and most study participants were male (26% female). Mean
LTL values, measured in each participant using a quantitative
polymerase chain reaction (qPCR) based technique as the ratio
of telomere repeat length to copy number of the single copy gene
36B4, were higher in the ERF study (x¯LTL = 1.85, SD = 0.35) than
in the RS (x¯LTL = 0.94, SD = 0.18) and BHF-FHS (x¯LTL = 1.37,
SD = 0.22). After adjusting LTL values for age and sex, mean LTL
was comparable between studies (Table 1).
The Manhattan plot and the distribution of the test statistic
[quantile-quantile (QQ) plot, λ = 1.04] of the WES analysis
in the ERF study are presented in Figures 1, 2, respectively.
We observed significant association of nine rare variants
[Minor Allele Frequency (MAF) between 0.2% and 0.5%] with
LTL as shown in Table 2. The significance threshold (p-
value < 1.42 × 10−7) was adjusted for multiple testing using
Bonferroni correction based on the number of variants in the
analysis (0.05/353,075 variants). Each variant was negatively
associated with LTL and the estimated effects of the minor allele
of these variants were large (−2.18 < standardized β < −1.34),
suggesting a significant decrease in LTL for each minor allele.
The top eight variants are located in a dense region on
chromosome 11q22.3 (position range: 108004687 – 108384666,
Figure 3) and appear to be a part of a haplotype that spans
the C11orf65, ACAT1, NPAT, ATM, KDELC2, and EXPH5 genes.
A haplotype can describe a pair of genes inherited together from
one parent on one chromosome, or it can describe all of the genes
on a chromosome that were inherited together from a single
parent. This haplotype segregates with shorter LTL in a family
(Supplementary Figure 1), where it is carried by 14 individuals,
11 of whom were related within 4 generations according to the
TABLE 1 | Descriptive statistics of the study populations.
ERF RS BHF-FHS
N 1303 1257 674
Mean age (SD) 48.9 (15.0) 74.5 (7.7) 58.0 (8.2)
Age range 18.2–95.7 55.0–105.8 36.0–81.0
% female 60.5 57.0 25.8
Mean LTL (SD) 1.85 (0.35) 0.94 (0.18) 1.37 (0.22)
LTL range 0.77–3.17 0.31–1.79 0.69–2.14
Adjusted mean 8.85 × 10−18 (0.32) 1.37 × 10−17 (0.18) 1.11 × 10−10 (0.21)
LTL (SD)*
Adjusted LTL −1.15–1.08 −0.71–0.89 −0.63–0.71
range*
ERF = Erasmus Rucphen Family study; RS = Rotterdam Study; BHF-FHS = British
Heart Foundation Family Heart Study; N = Number of variants; SD = Standard
Deviation, LTL = Leukocyte Telomere Length. *LTL values were adjusted for age
and sex and information on residuals is shown.
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FIGURE 1 | Manhattan plot of the association analysis with LTL in the ERF study. This plot shows –log10 transformed p-values (y-axis) for all variants present in the
association analysis according to their position on each chromosome (x-axis). The red dashed line represents the Bonferroni corrected p-value threshold for
significance (p-value < 1.42 × 10−7), while the blue dashed line represents the p-value threshold for suggestive significance (p-value ≤ 1.42 × 10−4).
pedigree data (Figure 4). Further, the genetic kinship estimates
show that the other three individuals are also related within 3–4
generations. These 8 variants are in strong linkage disequilibrium
(pairwise LD: r2 between 0.93 and 1.00, D′ = 1) and show very
similar p-values. The top variant rs185270276 is located in an
intron of the C11orf65 gene (MAF = 0.5%, β = −1.34, SE =
0.25, p-value = 7.99 × 10−8). The next six variants significantly
associated with LTL (MAF = 0.5%, β = −1.38, SE = 0.26,
p-value = 1.21 × 10−7) are located in the ACAT1, NPAT,
ATM/C11orf65, KDELC2, and EXPH5 genes. Two of these six
FIGURE 2 | Quantile-quantile plot of the association analysis with LTL in the
ERF study. The QQ-plot shows the observed test statistics (y-axis) plotted
against the expected values of the test statistics (x-axis) (X2-distribution). The
red line shows the distribution under the null hypothesis.
variants are missense variants: rs79119325 (NPAT, PolyPhen = 1,
CADD score = 18.1) and rs12146512 (EXPH5, PolyPhen = 0.624,
CADD score = 4.5). The eighth significant variant, rs2234993,
is located within an intron of ATM (MAF = 0.5%, β = −1.37,
SE = 0.26, p-value = 1.25 × 10−7). The ninth significant variant,
rs144114619 (MAF = 0.2%, p-value = 1.29× 10−7), is a missense
variant located on chromosome six in the BTN3A1 gene, which
is predicted to be damaging (PolyPhen = 1, CADD score = 12.2)
and has the largest effect size (β = −2.18, SE = 0.41). There were
six carriers of this variant in the ERF population. Interestingly,
four of these carriers are also carriers of the rare variants in the
chromosome 11q22.3 region (Supplementary Figure 2).
For replication analysis, we used WES data from two
independent cohorts of European ancestry, the RS and the BHF-
FHS. Results of the replication analysis are shown in Table 3,
together with the results of the meta-analysis of summary
statistics from all three cohorts for these variants. Six out of
nine rare variants significantly associated with LTL in the ERF
study (located in ACAT1, NPAT, ATM/C11orf65, EXPH5, and
BTN3A1) were present in the RS and/or the BHF-FHS but
were not significantly (p-value ≥ 0.21) associated with LTL
(p-value < 0.025, 0.05/2 independent tests). The direction of
effect of most variants was similar in the ERF study and the
RS, while the BHF-FHS showed opposite direction of effect for
most variants. Three variants, located in C11orf65, KDELC2, and
ATM, were not present in the RS and BHF-FHS data. As these are
unique to an isolated population, we were unable to confirm or
reject their association with LTL in the replication cohorts.
Finally, to increase the statistical power, we performed an
inverse-variance weighted meta-analysis of the association results
from all three cohorts using METAL software. Variants were
included in the meta-analysis if they were present in at least two
out of three cohorts and had a minimum minor allele count of five
in one or more cohorts, resulting in a multiple testing corrected
significance threshold of 3.02 × 10−7 (0.05/165,311 variants).
The top results of the meta-analysis (p-value < 3.02 × 10−4) are
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TABLE 2 | Significant variants from the association analysis in the ERF study.
REF/ PolyPhen PhastCons CADD
rsID Gene Chr Position* MAF ALT GVS function** score** score** score** β SE p-value
rs185270276 C11orf65 11 108263828 0.005 T/C Intron Unknown 0 6.51 −1.34 0.25 7.99 × 10−8
rs12365364 ACAT1 11 108004687 0.005 G/A Intron Unknown 0 3.28 −1.38 0.26 1.21 × 10−7
rs79119325 NPAT 11 108032614 0.005 C/T Missense 1 0.998 18.13 −1.38 0.26 1.21 × 10−7
rs3092910 ATM,C11orf65 11 108180917 0.005 T/C Intron, synonymous Unknown 0.997 9.87 −1.38 0.26 1.21 × 10−7
rs3218711 ATM,C11orf65 11 108236264 0.005 C/G 3-prime-UTR, intron Unknown 0.002 5.56 −1.38 0.26 1.21 × 10−7
rs11212668 KDELC2 11 108352576 0.005 T/C Intron Unknown 0 1.44 −1.38 0.26 1.21 × 10−7
rs12146512 EXPH5 11 108384666 0.005 T/C Missense 0.624 0.011 4.47 −1.38 0.26 1.21 × 10−7
rs2234993 ATM 11 108129599 0.005 C/G Intron Unknown 0 4.25 −1.37 0.26 1.25 × 10−7
rs144114619 BTN3A1 6 26408145 0.002 T/A Missense 1 0.002 12.24 −2.18 0.41 1.29 × 10−7
Chr = Chromosome; MAF = Minor Allele Frequency; REF = Reference allele; ALT = Alternative allele; CADD = Combined Annotation Dependent Depletion; β = effect of
the minor allele; SE = Standard Error. *Position according to Hg19. **Seattleseq Annotation Database 138.
FIGURE 3 | Regional association plot for the top hits on chromosome 11. The plot was constructed using LocusZoom (http://locuszoom.org/). The –log10
transformed p-values are plotted on the y-axis. The x-axis shows the position of the variants (dots) on chromosome 11 and the genes in this region. The most
significant variant (rs185270276) is shown in purple and the color of the dots indicates the extend of linkage disequilibrium between the variant and the top variant.
available in Table 4 and in Supplementary Table 1, which also
contains cohort specific information. The Manhattan and QQ-
plots are provided in Supplementary Figures 3, 4, respectively.
The λ of 0.97 suggests the power has been low. Although there
were no variants genome-wide significantly associated with LTL
in the meta-analysis after adjusting for multiple testing, many
of the top findings show a consistent effect across cohorts.
The variant most significantly associated with LTL was a highly
conserved synonymous variant (PhastCons score = 0.999) located
in the RPL8 gene on chromosome 8 (p-value = 1.48 × 10−6),
which is predicted to be deleterious (CADD score = 15.11).
Additionally, we used the meta-analysis results to perform a
look-up of variants in loci identified by previous European
ancestry GWASs (Supplementary Table 2). There were 153
variants present in these loci and we found suggestive evidence
(p-valuemeta < 3.02 × 10−4) for a positive association of a
rare variant with LTL (rs181080831, β = 0.74, SE = 0.19,
p-value = 1.18× 10−4) in the known RTEL1 locus.
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FIGURE 4 | Segregation plot of the rare variants on chromosome 11q22.3 in the ERF study. The carriers of the rare variants located on chromosome 11q22.3 are
depicted in red. The T/S ratio is added below the individuals of whom whole-exome sequencing data was available. Squares are males and rounds are females.
Deceased individuals are denoted by a line through that specific individual. One person is twice in the pedigree, this is shown with the dotted line.
DISCUSSION
In the family-based ERF study, we identified nine rare variants
(MAF between 0.2% and 0.5%) associated with LTL by
performing a WES association analysis. The eight most
significantly associated variants are located in a region on
chromosome 11q22.3 and segregate together with shorter
LTL in one family. This region contains the ATM locus
that has previously been shown to be involved in telomere
maintenance and genomic stability and is thus an obvious
candidate gene. In the meta-analysis of discovery and replication
cohorts, we identified another rare missense variant in the
RPL8 gene strongly associated with LTL. Although we
were not able to replicate either of the associations, both
ATM and RPL8 have been previously found to be strong
predictors of telomere length (ATM) and chronological age
(ATM and RPL8).
Interestingly, we identified three unique rare variants in the
ATM (Ataxia Telangiectasia Mutated) gene associated with LTL
in the ERF study. ATM is the homolog of the Tel1 gene in yeast
(Greenwell et al., 1995) and has been implicated in important
telomere maintenance processes (Pandita, 2002; Lee et al., 2015;
Tong et al., 2015). The ATM protein kinase is a master controller
of cell cycle checkpoint signaling pathways required for cell
response to DNA damage and for genomic stability (https:
//www.ncbi.nlm.nih.gov/gene/?term=472). Additionally, ATM
kinase is necessary for telomere elongation (Lee et al., 2015;
Tong et al., 2015). ATM is involved in the genetic disorder
ataxia telangiectasia (AT), which is characterized by cerebellar
ataxia, oculocutaneous telangiectasia, immunodeficiency, and
a predisposition to cancer (Savitsky et al., 1995). Cells of
AT patients also show telomeric fusions and have accelerated
telomere shortening with increasing age (Metcalfe et al.,
1996). Furthermore, ATM was significantly associated with
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chronological age in a meta-analysis of gene expression profiles,
showing lower transcript abundance in older individuals (Peters
et al., 2015). Although genetic variants in ATM have been
associated with various cancers (Barrett et al., 2011; Helgason
et al., 2015; Ransohoff et al., 2017; Scelo et al., 2017), only one
genetic variant in ATM, rs227080, was genome-wide significantly
associated with LTL in a Singaporean Chinese population
(Dorajoo et al., 2019). This variant was not significantly
associated with LTL in the ERF study, the Rotterdam Study or the
BHF-FHS, implicating it was not driving the association observed
in the current study.
Segregation analysis of the variants within the chromosome
11q22.3 region in the ERF study showed that the variants
segregate with shorter LTL in one family. We did not detect
a specific disease that segregates in this family, which may be
explained by the relatively young age of most of the carriers.
In the replication analysis, we were not able to confirm the
association of the nine variants associated with LTL in the RS and
BHF-FHS, due to lack of association (six variants) or absence of
the variant in the replication cohorts (three variants). However, it
is possible this signal comes from variants that are family-specific
and thus may not be transferable to the general population.
Likewise, it may also be that the whole haplotype has an effect
on telomere length, an haplotype that is most likely unique to
the isolated ERF population. At this locus, the ATM gene is
currently the most likely causative gene. Lastly, we performed
a meta-analysis of the three cohorts. The top variant of the
meta-analysis is located in RPL8 (Ribosomal Protein L8). This
is interesting as RPL8, together with six other RPL genes, was
negatively associated with chronological age (Peters et al., 2015).
In this transcriptomic study, Peters et al. identified 1,497 genes
whose expression level changes associated with age; this gene
list includes RPL8 and ATM. We additionally found suggestive
evidence for an association of a novel rare variant in the known
RTEL1 locus. It would be interesting to perform a WES or
whole-genome sequencing meta-analysis with larger sample size
to increase the statistical power.
The advantage of our study is that we used a family-based
setting that allowed us to show segregation of the variants
located on chromosome 11q22.3 in a family. The ERF study
population has shown a low immigration rate and a high level
of inbreeding, which has increased the frequency of many rare
alleles (Pardo et al., 2005). Another advantage is that all three
studies used the standardized qPCR method to quantify LTL.
However, there are also several limitations to our study. The first
limitation is that our findings in the ERF study are not easy to
generalize to the general population as these findings may be
family-specific. However, we identified genes that are known to
be related to telomere processes and thus are plausible candidate
genes. The second limitation of our study may be that we used
blood measurements of telomere length instead of tissue specific
measurements, although previous studies have shown that mean
telomere length in blood and other tissues are highly correlated
(Okuda et al., 2002; Wilson et al., 2008) and, therefore, we expect
this did not influence our findings. The third limitation is the
difference in LTL distribution between the three studies, which
may be explained by the different age distributions in the studies.
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TABLE 4 | Suggestive findings of the meta-analysis (p-value ≤ 3.02 × 10−4).
REF/ PolyPhen PhastCons CADD
rsID Gene Chr Position* ALT GVS function** score** score** score** β SE p-value Direction†
8:146017422 RPL8 8 146017422 G/A Synonymous Unknown 0.999 15.11 1.93 0.40 1.48 × 10−6 +++
rs77919685 LATS2 13 21563311 G/A Missense 0.002 0 7.001 0.44 0.09 2.23 × 10−6 +++
rs56041036 ZFPM1 16 88599023 A/G Synonymous-near-
splice
Unknown 0.998 10.77 −0.20 0.04 7.44 × 10−6 ---
rs199779997 MGA 15 42058958 A/C Missense 0.001 0.866 9.45 1.77 0.40 8.60 × 10−6 +++
rs4895944 VNN2 6 133070995 G/T Missense,
non-coding-exon
0.038 0.003 16.69 −1.29 0.29 8.99 × 10−6 --?
rs7735563 RAPGEF6 5 130764936 T/C Intron Unknown 1 19.08 −0.77 0.18 1.53 × 10−5 ---
rs189691392 SF3B5 6 144416667 G/A 5-prime-UTR Unknown 0 7.119 −1.82 0.42 1.77 × 10−5 -?-
rs138765444 ZKSCAN4 6 28219377 A/G Synonymous, intron Unknown 0.036 9.324 −1.27 0.30 2.59 × 10−5 ---
rs1783091 none 21 33964605 T/C Intergenic Unknown 0.004 0.154 0.22 0.05 2.67 × 10−5 +?+
rs2170177 DOCK3 3 51349887 C/A Intron Unknown 0 0.044 −0.36 0.09 5.06 × 10−5 ---
rs5930 LDLR 19 11224265 A/G Synonymous Unknown 0.001 0.579 −0.10 0.03 5.73 × 10−5 ---
rs55648406 TUB 11 8060566 G/A Missense, intron 0.086 1 15.76 −0.62 0.16 5.85 × 10−5 ---
rs140456008 SLC35G2 3 136574420 A/G Missense 0.941 1 10.84 1.89 0.47 6.67 × 10−5 ++?
rs139380413 COL8A1 3 99513830 G/A Missense 0.071 0.966 11.23 −1.26 0.32 7.88 × 10−5 ---
rs11656725 LRRC48 17 17900726 C/T Intron Unknown 0 0.471 0.38 0.10 8.25 × 10−5 +?+
rs7193541 RFWD3 16 74664743 T/C Missense 0.008 0.485 9.1 −0.10 0.03 8.28 × 10−5 ---
rs17222435 SLC28A1 15 85488335 C/T Intron Unknown 0 3.598 0.69 0.18 9.07 × 10−5 +++
rs117223521 none 8 38964715 T/C Upstream-gene Unknown 0 1.194 −1.36 0.35 1.01 × 10−4 -?-
rs11700220 MTG2 20 60770931 A/G Missense 1 1 21.6 0.47 0.12 1.03 × 10−4 +++
rs187466877 GPN1 2 27862872 A/G Intron Unknown 0 1.47 0.85 0.22 1.05 × 10−4 +?+
rs56188826 MARK1 1 220791870 C/T Synonymous Unknown 0.123 6.414 0.41 0.11 1.14 × 10−4 +?+
rs1872592 PIF1 15 65113493 G/A Intron Unknown 0 0.005 −0.10 0.02 1.15 × 10−4 ---
rs73056605 CLEC4C 12 7894056 G/A Missense 0.037 0 0.005 0.11 0.03 1.18 × 10−4 +++
rs181080831 RTEL1, RTEL1-
TNFRSF6B
20 62326874 G/A Intron,
non-coding-exon,
synonymous
Unknown 0 4.04 0.74 0.19 1.18 × 10−4 +++
rs13014800 CENPA 2 27015118 G/A Intron Unknown 0.163 11.67 −0.13 0.03 1.23 × 10−4 -?-
rs143463783 TRIM27 6 28889741 G/A Synonymous Unknown 1 9.216 −1.22 0.32 1.24 × 10−4 -?-
rs374215951 PIEZO1 16 88788318 G/A Synonymous Unknown 0.21 0.893 −2.57 0.67 1.31 × 10−4 -?-
rs181215404 EPPK1 8 144941659 G/A Synonymous Unknown 0.011 4.835 0.94 0.25 1.32 × 10−4 +?+
rs377359525 FTCD 21 47572869 A/G Missense 1 1 16.44 1.68 0.44 1.33 × 10−4 +++
rs10936599 MYNN 3 169492101 C/T Synonymous,
non-coding-exon,
5-prime-UTR
Unknown 1 10.1 −0.11 0.03 1.38 × 10−4 ---
rs74730846 STXBP5L 3 120924764 C/T Intron-near-splice Unknown 0.629 5.818 −0.19 0.05 1.39 × 10−4 -?-
rs137853096 HSD17B4 5 118788316 G/A Missense,
5-prime-UTR
1 1 24 −0.73 0.19 1.67 × 10−4 --?
rs41284136 IFIT3 10 91087805 G/C 5-prime-UTR Unknown 0 7.796 0.40 0.11 1.76 × 10−4 +++
rs58106741 SLC4A1AP 2 27886820 G/T Synonymous Unknown 0 5.939 0.70 0.19 1.80 × 10−4 +?+
rs58068845 UTP6 17 30200363 G/A Intron Unknown 0 4.223 0.35 0.09 1.90 × 10−4 +++
rs200602887 GREB1 2 11751072 G/C Synonymous Unknown 0.986 10.5 −1.02 0.27 2.01 × 10−4 ---
rs141180155 LRP2 2 170127559 G/A Synonymous, intron Unknown 0 13.06 −0.36 0.10 2.08 × 10−4 ---
rs7837242 LONRF1 8 12600622 C/T Intron Unknown 0.001 4.941 −0.18 0.05 2.08 × 10−4 -?-
rs115018606 C2orf16 2 27799773 A/C Missense 0.972 0.002 5.869 0.41 0.11 2.12 × 10−4 +?+
rs151309008 REXO2 11 114310345 C/T Missense 0.437 1 17.76 −0.64 0.17 2.12 × 10−4 ---
rs143759519 PYGL 14 51382637 G/A Missense 1 0.975 34 0.55 0.15 2.13 × 10−4 +++
rs10936600 LRRC34 3 169514585 A/T Missense 1 0.001 12.07 −0.11 0.03 2.14 × 10−4 ---
rs117178504 DYNC2H1 11 103153788 C/A Synonymous Unknown 0.996 8.615 0.38 0.10 2.18 × 10−4 +++
rs367644268 COA5 2 99224742 C/T Intron Unknown 0.015 8.626 −1.42 0.39 2.28 × 10−4 --?
rs146979490 GPN1 2 27864089 A/G Intron Unknown 0.025 11.52 0.51 0.14 2.43 × 10−4 +++
rs146033252 MTA3, OXER1 2 42991127 G/A Missense, intron 0.084 0.023 8.404 0.71 0.19 2.48 × 10−4 +++
(Continued)
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TABLE 4 | Continued
REF/ PolyPhen PhastCons CADD
rsID Gene Chr Position* ALT GVS function** score** score** score** β SE p-value Direction†
rs141280036 PADI4 1 17634718 A/G Missense 0.992 0.881 13.72 0.79 0.22 2.51 × 10−4 +++
rs79400176 DZANK1 20 18414309 C/T Missense 0.129 0.994 2.801 −0.36 0.10 2.55 × 10−4 ---
rs116604207 RBM5 3 50147061 G/A Synonymous,
non-coding-exon
Unknown 0.453 11.12 0.79 0.22 2.62 × 10−4 +++
rs41307740 LBR 1 225601614 C/A Intron Unknown 0.004 5.956 −0.65 0.18 2.76 × 10−4 -?-
rs369623673 ELAC2 17 12899160 C/T Intron Unknown 0 6 0.93 0.26 2.77 × 10−4 +?+
rs9997727 C4orf50 4 5969113 G/A Intron Unknown 0 0.613 −0.10 0.03 2.85 × 10−4 ---
rs150538926 PDZD2 5 32037369 C/T Synonymous Unknown 0 0.482 0.40 0.11 2.87 × 10−4 +++
rs55868421 TRIM5 11 5688948 A/G Intron-near-splice,
intron
Unknown 0 5.512 0.44 0.12 2.94 × 10−4 +++
rs323895 ACY1,
ABHD14A-
ACY1
3 52021316 A/G Intron Unknown 0 1.818 −0.36 0.10 3.00 × 10−4 ---
rs7188880 RFWD3 16 74664810 A/T Synonymous Unknown 1 10.78 −0.09 0.02 3.01 × 10−4 ---
Chr = Chromosome; REF = Reference allele; ALT = Alternative allele; CADD = Combined Annotation Dependent Depletion; β = effect of the minor allele; SE = Standard
Error. *Position according to Hg19. **Seattleseq Annotation Database 138. †Order of cohorts in direction column: ERF, RS, BHF-FHS; Direction of effect represented by
− (negative association) + (positive association) or ? (not available).
Mean age is lowest in the ERF study (49 years), highest in the RS
(75 years) and mean age in the BHF-FHS is in between (58 years).
As LTL decreases significantly with age (Lindsey et al., 1991;
Slagboom et al., 1994; Blackburn, 2001) and is associated with
mortality (Cawthon et al., 2003; Kimura et al., 2008; Fitzpatrick
et al., 2011; Honig et al., 2012; Deelen et al., 2014; Rode et al.,
2015; Marioni et al., 2016), the variation in LTL becomes less
with the aging populations. Mean LTL values were comparable
between studies after adjusting LTL values for age and sex. To
further standardize across the three cohorts, a z-transformation
of the LTL values was performed resulting in comparable
distributions with mean of zero and standard deviation of one.
Nevertheless, these differences between studies, together with
the small sample size of the BHF-FHS cohort, could potentially
explain the lack of replication. The fourth limitation is that we
were unable to calculate the effect of the variants on telomere
length in base pairs because of the quantification method of LTL
in our study together with the z-transformation that was applied
to the LTL values to standardize across the cohorts.
To conclude, this first study using WES data to search
for rare genetic variants associated with LTL has identified
interesting variants and genes associated with shorter LTL.
Eight out of nine rare variants associated with LTL are located
on chromosome 11q22.3 and all variants segregate within an
ERF family. As we were not able to replicate findings, future
studies should further investigate this region and the other genes
identified in this study to confirm their involvement in telomere
length regulation.
MATERIALS AND METHODS
Study Populations
Our discovery population consisted of participants from the
family-based Erasmus Rucphen Family (ERF) study. The
ERF study comprises approximately 3,000 inhabitants of a
recent genetically isolated community in the Southwest of
the Netherlands, studied as part of the Genetic Research in
Isolated Population program (Pardo et al., 2005). All ERF
participants are descendants of 22 founder couples who had
at least six children baptized in the community church in
the 18th century, or their spouses. Baseline data collection,
including blood withdrawal, took place between 2002 and
2005. As the ERF population shows a low rate of immigration
and a high level of inbreeding, the frequency of several
rare alleles is increased in this population (Pardo et al.,
2005). The ERF study was approved by the Medical Ethics
Commitee of the Erasmus Medical Center (MC), Rotterdam,
Netherlands. All participants provided written informed consents
and all investigations were carried out in accordance with the
Declaration of Helsinki.
The replication cohorts included participants from the
Rotterdam Study (RS) and the British Heart Foundation Family
Heart Study (BHF-FHS). The RS is a prospective cohort study
ongoing since 1990 in the well-defined Ommoord district in
Rotterdam, The Netherlands. The original RS cohort (RS-I)
included 7,983 individuals of 55 years of age or over. At baseline,
participants were interviewed at home and had an extensive set
of examinations, which were repeated every 3–4 years (Ikram
et al., 2017). The Rotterdam Study has been approved by the
Medical Ethics Committee of the Erasmus MC and by the Dutch
Ministry of Health, Welfare and Sport. The Rotterdam Study
has been entered into the Netherlands National Trial Register
(NTR; www.trialregister.nl) and into the WHO International
Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/
network/primary/en/) under shared catalogue number NTR6831.
All participants provided written informed consent to participate
in the study and to have their information obtained from
treating physicians.
The British Heart Foundation Family Heart study recruited
families with at least two siblings diagnosed with premature
(<66 years) coronary artery disease (CAD) within the
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United Kingdom between 1998 and 2003. Full details are
provided elsewhere (Samani et al., 2005, 2007).
Telomere Length
Mean LTL values in the ERF study and the BHF-FHS
study were measured using a qPCR method in all samples
(Cawthon, 2002). The measurements were performed in
Leicester, United Kingdom, and details of the measurements
were previously described (Codd et al., 2010, 2013). In
summary, mean LTL was measured in leukocytes and
expressed as the ratio (T/S ratio) of telomere repeat
length (T) to the copy number of a single-copy gene,
36B4 (S). Samples were quantified relative to a calibrator
sample used on each run (DNA from the K562 cell line)
(Codd et al., 2010).
In the RS, mean LTL values were also measured using
a qPCR assay based on the method described by Cawthon
(2002) with minor modifications. For each sample the telomere
and 36B4 assay were run in separate wells but in the same
384 wells PCR plate. Each reaction contained 5 ng DNA,
1 uM of each of the telomere primers (tel1b-forward: GGTT
TGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT, tel2b-
reverse: GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTA
CCCT) or 250 nM of the 36B4 primers (36B4u-forward: CAG
CAAGTGGGAAGGTGTAATCC, 36B4d-reverse: CCCATTCT
ATCATCAACGGGTACAA) and 1x Quantifast SYBR green
PCR Mastermix (Qiagen). The reactions for both assays were
performed in duplicate for each sample in a 7900HT machine
(Applied Biosystems). Ct values and PCR efficiencies were
calculated per plate using the MINER algorithm (Zhao and
Fernald, 2005). Duplicate Ct values that had a Coefficient of
Variance (CV) of more than 1% were excluded from further
analysis. Using the average Ct value per sample and the average
PCR efficiency per plate the samples were quantified using the
formula Q = 1/(1 + PCR eff)ˆCt. The relative telomere length
was calculated by dividing the Q of the telomere assay by the Q
of the 36B4 assay. To validate the assay 96 random samples were
run twice and the CV of that experiment was 4.5%.
Exome Sequencing
The exomes of 1,336 ERF participants were sequenced at
the Erasmus Center for Biomics of the department of Cell
Biology, Erasmus MC, The Netherlands. The exomes of a
randomly selected subset of 2,628 individuals from the RS-I
population were sequenced at the Human Genotyping facility
of the Department of Internal Medicine, Erasmus MC, The
Netherlands. Details of the methods and quality control for
ERF and RS are described elsewhere (Amin et al., 2016; van
Rooij et al., 2017). In total, 1,303 ERF participants and 1,257 RS
participants had both exome sequence and LTL data available
and were included in this analysis. A subset of the BHF-FHS,
comprising of 674 unrelated individuals of Caucasian ancestry
who had previously undergone exome sequencing as part of
the Leicester Myocardial Infarction Study (Khera et al., 2017)
and had LTL data available (Codd et al., 2010) were included
in this analysis.
Statistical Analyses
For each individual cohort quantitative trait association analysis
was performed using Rare Variant tests (RVtests) software,
which supports the analysis of related individuals (Zhan et al.,
2016). Association analysis was performed using a score test,
assuming an additive model, suitable for analysis with related
and unrelated individuals. We applied a z-transformation of
LTL values for the three cohorts separately to standardize values
across cohorts. All analyses were adjusted for age, sex and
batch effects (if needed). Furthermore, we adjusted for familial
relationships in ERF using the kinship matrix estimated from
the genotyped data, while in the RS we corrected for the first
four principal components as the fourth principal component
was significantly associated with LTL. Only variants with a minor
allele count ≥ 5 were included.
In the ERF study, we calculated the pairwise LD (r2 and D′)
between the top eight variants on chromosome 11 that were
significantly associated with LTL using the –ld command
of PLINK 1.9 software (Chang et al., 2015) (www.cog-
genomics.org/plink/1.9/). Additionally, we performed an inverse-
variance weighted meta-analysis using METAL software (Willer
et al., 2010). In the analysis using data of the family-based
ERF study, we corrected the significance thresholds for multiple
testing using Bonferroni correction, resulting in a significance
threshold of 1.42 × 10−7 (0.05/353,075). In the replication
analysis, the multiple testing corrected p-value thresholds was
0.025 (0.05/2 independent tests). In the meta-analysis, we
adjusted for the number of variants tested, resulting in a
significance threshold of 3.02× 10−7 (0.05/165,311).
DATA AVAILABILITY STATEMENT
The datasets analyzed for each individual cohort can be requested
by contacting the responsible Principal Investigator. Because of
restrictions based on privacy regulations and informed consent
of the participants, data cannot be made freely available in a
public repository. For the Rotterdam Study data, requests should
be directed toward the management team of the Rotterdam
Study (secretariat.epi@erasmusmc.nl), which has a protocol for
approving data requests.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by their respective Medical Ethics Boards and
all investigations were carried out in accordance with the
Declaration of Helsinki. The patients/participants provided their
written informed consent to participate in this study.
AUTHOR CONTRIBUTIONS
AS, NA, and CD designed the study and wrote the manuscript.
AS, SW, CN, and SA performed the analyses. LB, PA, RB, MD,
MH, JR, RK, and NA were involved in the data collection and
Frontiers in Genetics | www.frontiersin.org 9 April 2020 | Volume 11 | Article 337
fgene-11-00337 April 29, 2020 Time: 18:31 # 10
van der Spek et al. Exome-Wide Association Study of Telomere Length
provided the data. WI, NS, MI, AU, and CD were involved in the
supervision of individual cohorts. AS, SW, CN, DV, NS, VC, NA,
and CD interpreted the results. All authors critically reviewed and
approved the manuscript.
FUNDING
The ERF study as a part of EUROSPAN (European Special
Populations Research Network) was supported by European
Commission FP6 STRP grant number 018947 (LSHG-CT-
2006-01947) and also received funding from the European
Community’s Seventh Framework Programme (FP7/2007-
2013)/grant agreement HEALTH-F4-2007-201413 by the
European Commission under the programme “Quality of Life
and Management of the Living Resources” of 5th Framework
Programme (No. QLG2-CT-2002-01254). High-throughput
analysis of the ERF data was supported by joint grant from
Netherlands Organization for Scientific Research and the Russian
Foundation for Basic Research (NWO-RFBR 047.017.043).
Exome sequencing analysis in ERF was supported by the ZonMw
grant (project 91111025). AS and CD have used exchange grants
from Personalized pREvention of Chronic DIseases consortium
(PRECeDI) (H2020-MSCA-RISE-2014). The generation and
management of the exome sequencing data for the Rotterdam
Study was executed by the Human Genotyping Facility of the
Genetic Laboratory of the Department of Internal Medicine,
Erasmus MC, the Netherlands. The Exome Sequencing data
set was funded by the Netherlands Genomics Initiative
(NGI)/Netherlands Organisation for Scientific Research (NWO)
sponsored Netherlands Consortium for Healthy Aging (NCHA;
project nr. 050-060-810), by the Genetic Laboratory of the
Department of Internal Medicine, Erasmus MC, and by the
and by a Complementation Project of the Biobanking and
Biomolecular Research Infrastructure Netherlands (BBMRI-NL;
www.bbmri.nl; project number CP2010-41). The Rotterdam
Study was funded by Erasmus Medical Center and Erasmus
University, Rotterdam, Netherlands Organization for the
Health Research and Development (ZonMw), the Research
Institute for Diseases in the Elderly (RIDE), the Ministry of
Education, Culture and Science, the Ministry for Health, Welfare
and Sports, the European Commission (DG XII), and the
Municipality of Rotterdam. The BHF-FHS study was funded
by the British Heart Foundation (BHF). Exome sequencing of
the Leicester Myocardial Infarction Study was supported by
grant 5U54HG003067 from the National Institutes of Health.
CN and NS were supported by the BHF. NS is a NIHR
Senior Investigator.
ACKNOWLEDGMENTS
ERF study: we are grateful to all study participants and
their relatives, general practitioners, and neurologists for their
contributions and to P. Veraart for her help in genealogy,
J. Vergeer for the supervision of the laboratory work and P.
Snijders for his help in data collection. Rotterdam Study: we
thank Mr. Pascal Arp, Ms. Mila Jhamai, and Mr. Marijn Verkerk
for their help in creating the RS-Exome Sequencing database.
We are grateful to the study participants, the staff from the
Rotterdam Study and the participating general practitioners
and pharmacists.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fgene.
2020.00337/full#supplementary-material
REFERENCES
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B.,
et al. (1992). Telomere length predicts replicative capacity of human fibroblasts.
Proc. Natl. Acad. Sci. U.S.A. 89, 10114–10118. doi: 10.1073/pnas.89.21.10114
Amin, N., Jovanova, O., Adams, H. H., Dehghan, A., Kavousi, M., Vernooij, M. W.,
et al. (2016). Exome-sequencing in a large population-based study reveals a rare
Asn396Ser variant in the LIPG gene associated with depressive symptoms. Mol.
Psychiatry 22, 537–543. doi: 10.1038/mp.2016.101
Andrew, T., Aviv, A., Falchi, M., Surdulescu, G. L., Gardner, J. P., Lu, X., et al.
(2006). Mapping genetic loci that determine leukocyte telomere length in a
large sample of unselected female sibling pairs. Am. J. Hum. Genet. 78, 480–486.
doi: 10.1086/500052
Barrett, J. H., Iles, M. M., Harland, M., Taylor, J. C., Aitken, J. F., Andresen, P. A.,
et al. (2011). Genome-wide association study identifies three new melanoma
susceptibility loci. Nat. Genet. 43, 1108–1113.
Benetos, A., Gardner, J. P., Zureik, M., Labat, C., Xiaobin, L., Adamopoulos,
C., et al. (2004). Short telomeres are associated with increased carotid
atherosclerosis in hypertensive subjects. Hypertension 43, 182–185. doi: 10.
1161/01.hyp.0000113081.42868.f4
Bischoff, C., Graakjaer, J., Petersen, H. C., Hjelmborg, J., Vaupel, J. W., Bohr,
V., et al. (2005). The heritability of telomere length among the elderly and
oldest-old. Twin Res. Hum. Genet. 8, 433–439. doi: 10.1375/twin.8.5.433
Blackburn, E. H. (2000). Telomere states and cell fates. Nature 408, 53–56. doi:
10.1038/35040500
Blackburn, E. H. (2001). Switching and signaling at the telomere. Cell 106, 661–673.
doi: 10.1016/s0092-8674(01)00492-5
Blackburn, E. H., and Gall, J. G. (1978). A tandemly repeated sequence at the
termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol.
Biol. 120, 33–53. doi: 10.1016/0022-2836(78)90294-2
Bojesen, S. E., Pooley, K. A., Johnatty, S. E., Beesley, J., Michailidou, K., Tyrer, J. P.,
et al. (2013). Multiple independent variants at the TERT locus are associated
with telomere length and risks of breast and ovarian cancer. Nat. Genet. 45,
371–384.
Broer, L., Codd, V., Nyholt, D. R., Deelen, J., Mangino, M., Willemsen, G.,
et al. (2013). Meta-analysis of telomere length in 19,713 subjects reveals high
heritability, stronger maternal inheritance and a paternal age effect. Eur. J. Hum.
Genet. 21, 1163–1168. doi: 10.1038/ejhg.2012.303
Brouilette, S., Singh, R. K., Thompson, J. R., Goodall, A. H., and Samani, N. J.
(2003). White cell telomere length and risk of premature myocardial infarction.
Arterioscler. Thromb. Vasc. Biol. 23, 842–846. doi: 10.1161/01.atv.0000067426.
96344.32
Brouilette, S. W., Moore, J. S., Mcmahon, A. D., Thompson, J. R., Ford, I.,
Shepherd, J., et al. (2007). Telomere length, risk of coronary heart disease, and
statin treatment in the West of Scotland Primary Prevention Study: a nested
case-control study. Lancet 369, 107–114. doi: 10.1016/s0140-6736(07)60071-3
Frontiers in Genetics | www.frontiersin.org 10 April 2020 | Volume 11 | Article 337
fgene-11-00337 April 29, 2020 Time: 18:31 # 11
van der Spek et al. Exome-Wide Association Study of Telomere Length
Cawthon, R. M. (2002). Telomere measurement by quantitative PCR. Nucleic Acids
Res. 30:e47.
Cawthon, R. M., Smith, K. R., O’brien, E., Sivatchenko, A., and Kerber, R. A. (2003).
Association between telomere length in blood and mortality in people aged 60
years or older. Lancet 361, 393–395. doi: 10.1016/s0140-6736(03)12384-7
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., and Lee, J. J.
(2015). Second-generation PLINK: rising to the challenge of larger and richer
datasets. Gigascience 4:7.
Codd, V., Mangino, M., Van Der Harst, P., Braund, P. S., Kaiser, M., Beveridge, A. J.,
et al. (2010). Common variants near TERC are associated with mean telomere
length. Nat. Genet. 42, 197–199. doi: 10.1038/ng.532
Codd, V., Nelson, C. P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J. L., et al.
(2013). Identification of seven loci affecting mean telomere length and their
association with disease. Nat. Genet. 45, 422–427.
Deelen, J., Beekman, M., Codd, V., Trompet, S., Broer, L., Hagg, S., et al. (2014).
Leukocyte telomere length associates with prospective mortality independent
of immune-related parameters and known genetic markers. Int. J. Epidemiol.
43, 878–886. doi: 10.1093/ije/dyt267
Dorajoo, R., Chang, X., Gurung, R. L., Li, Z., Wang, L., Wang, R., et al. (2019). Loci
for human leukocyte telomere length in the Singaporean Chinese population
and trans-ethnic genetic studies. Nat. Commun. 10:2491.
Fitzpatrick, A. L., Kronmal, R. A., Gardner, J. P., Psaty, B. M., Jenny, N. S., Tracy,
R. P., et al. (2007). Leukocyte telomere length and cardiovascular disease in
the cardiovascular health study. Am. J. Epidemiol. 165, 14–21. doi: 10.1093/
aje/kwj346
Fitzpatrick, A. L., Kronmal, R. A., Kimura, M., Gardner, J. P., Psaty, B. M.,
Jenny, N. S., et al. (2011). Leukocyte telomere length and mortality in the
cardiovascular health study. J. Gerontol. A Biol. Sci. Med. Sci. 66, 421–429.
Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaier, B., and
Petes, T. D. (1995). TEL1, a gene involved in controlling telomere length in
S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82,
823–829. doi: 10.1016/0092-8674(95)90479-4
Grodstein, F., Van Oijen, M., Irizarry, M. C., Rosas, H. D., Hyman, B. T., Growdon,
J. H., et al. (2008). Shorter telomeres may mark early risk of dementia:
preliminary analysis of 62 participants from the nurses’ health study. PLoS One
3:e1590. doi: 10.1371/journal.pone.0001590
Harris, S. E., Deary, I. J., Macintyre, A., Lamb, K. J., Radhakrishnan, K., Starr,
J. M., et al. (2006). The association between telomere length, physical health,
cognitive ageing, and mortality in non-demented older people. Neurosci. Lett.
406, 260–264. doi: 10.1016/j.neulet.2006.07.055
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., and
Allshire, R. C. (1990). Telomere reduction in human colorectal carcinoma and
with ageing. Nature 346, 866–868. doi: 10.1038/346866a0
Haycock, P. C., Heydon, E. E., Kaptoge, S., Butterworth, A. S., Thompson, A., and
Willeit, P. (2014). Leucocyte telomere length and risk of cardiovascular disease:
systematic review and meta-analysis. BMJ 349:g4227. doi: 10.1136/bmj.g4227
Helgason, H., Rafnar, T., Olafsdottir, H. S., Jonasson, J. G., Sigurdsson, A., Stacey,
S. N., et al. (2015). Loss-of-function variants in ATM confer risk of gastric
cancer. Nat. Genet. 47, 906–910. doi: 10.1038/ng.3342
Honig, L. S., Kang, M. S., Schupf, N., Lee, J. H., and Mayeux, R. (2012). Association
of shorter leukocyte telomere repeat length with dementia and mortality. Arch.
Neurol. 69, 1332–1339.
Houben, J. M., Giltay, E. J., Rius-Ottenheim, N., Hageman, G. J., and Kromhout,
D. (2011). Telomere length and mortality in elderly men: the zutphen elderly
study. J. Gerontol. A Biol. Sci. Med. Sci. 66, 38–44. doi: 10.1093/gerona/glq164
Ikram, M. A., Brusselle, G. G. O., Murad, S. D., Van Duijn, C. M., Franco, O. H.,
Goedegebure, A., et al. (2017). The Rotterdam Study: 2018 update on objectives,
design and main results. Eur. J. Epidemiol. 32, 807–850. doi: 10.1007/s10654-
017-0321-4
Khera, A. V., Won, H. H., Peloso, G. M., O’dushlaine, C., Liu, D., Stitziel, N. O.,
et al. (2017). Association of rare and common variation in the lipoprotein lipase
gene with coronary artery disease. JAMA 317, 937–946.
Kimura, M., Hjelmborg, J. V., Gardner, J. P., Bathum, L., Brimacombe, M., Lu, X.,
et al. (2008). Telomere length and mortality: a study of leukocytes in elderly
Danish twins. Am. J. Epidemiol. 167, 799–806. doi: 10.1093/aje/kwm380
Lee, S. S., Bohrson, C., Pike, A. M., Wheelan, S. J., and Greider, C. W. (2015). ATM
kinase is required for telomere elongation in mouse and human cells. Cell Rep.
13, 1623–1632. doi: 10.1016/j.celrep.2015.10.035
Levy, D., Neuhausen, S. L., Hunt, S. C., Kimura, M., Hwang, S. J., Chen, W.,
et al. (2010). Genome-wide association identifies OBFC1 as a locus involved in
human leukocyte telomere biology. Proc. Natl. Acad. Sci. U.S.A. 107, 9293–9298.
doi: 10.1073/pnas.0911494107
Lindsey, J., Mcgill, N. I., Lindsey, L. A., Green, D. K., and Cooke, H. J. (1991).
In vivo loss of telomeric repeats with age in humans. Mutat. Res. 256, 45–48.
doi: 10.1016/0921-8734(91)90032-7
Mangino, M., Christiansen, L., Stone, R., Hunt, S. C., Horvath, K., Eisenberg, D. T.,
et al. (2015). DCAF4, a novel gene associated with leucocyte telomere length.
J. Med. Genet. 52, 157–162. doi: 10.1136/jmedgenet-2014-102681
Mangino, M., Hwang, S. J., Spector, T. D., Hunt, S. C., Kimura, M., Fitzpatrick,
A. L., et al. (2012). Genome-wide meta-analysis points to CTC1 and ZNF676
as genes regulating telomere homeostasis in humans. Hum. Mol. Genet. 21,
5385–5394. doi: 10.1093/hmg/dds382
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter,
D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature
461, 747–753.
Marioni, R. E., Harris, S. E., Shah, S., Mcrae, A. F., Von Zglinicki, T., Martin-Ruiz,
C., et al. (2016). The epigenetic clock and telomere length are independently
associated with chronological age and mortality. Int. J. Epidemiol. 45, 424–432.
doi: 10.1093/ije/dyw041
Martin-Ruiz, C., Dickinson, H. O., Keys, B., Rowan, E., Kenny, R. A., and
Von Zglinicki, T. (2006). Telomere length predicts poststroke mortality,
dementia, and cognitive decline. Ann. Neurol. 60, 174–180. doi: 10.1002/ana.
20869
Martin-Ruiz, C. M., Gussekloo, J., Van Heemst, D., Von Zglinicki, T., and
Westendorp, R. G. (2005). Telomere length in white blood cells is not associated
with morbidity or mortality in the oldest old: a population-based study. Aging
Cell 4, 287–290. doi: 10.1111/j.1474-9726.2005.00171.x
McCarthy, S., Das, S., Kretzschmar, W., Delaneau, O., Wood, A. R., Teumer, A.,
et al. (2016). A reference panel of 64,976 haplotypes for genotype imputation.
Nat. Genet. 48, 1279–1283. doi: 10.1038/ng.3643
Metcalfe, J. A., Parkhill, J., Campbell, L., Stacey, M., Biggs, P., Byrd, P. J., et al.
(1996). Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 13,
350–353. doi: 10.1038/ng0796-350
Needham, B. L., Rehkopf, D., Adler, N., Gregorich, S., Lin, J., Blackburn, E. H.,
et al. (2015). Leukocyte telomere length and mortality in the national health
and nutrition examination survey, 1999-2002. Epidemiology 26, 528–535. doi:
10.1097/ede.0000000000000299
Njajou, O. T., Hsueh, W. C., Blackburn, E. H., Newman, A. B., Wu, S. H., Li,
R., et al. (2009). Association between telomere length, specific causes of death,
and years of healthy life in health, aging, and body composition, a population-
based cohort study. J. Gerontol. A Biol. Sci. Med. Sci. 64, 860–864. doi: 10.1093/
gerona/glp061
Okuda, K., Bardeguez, A., Gardner, J. P., Rodriguez, P., Ganesh, V., Kimura,
M., et al. (2002). Telomere length in the newborn. Pediatr. Res. 52,
377–381.
Pandita, T. K. (2002). ATM function and telomere stability. Oncogene 21, 611–618.
doi: 10.1038/sj.onc.1205060
Pardo, L. M., Mackay, I., Oostra, B., Van Duijn, C. M., and Aulchenko, Y. S. (2005).
The effect of genetic drift in a young genetically isolated population. Ann. Hum.
Genet. 69, 288–295. doi: 10.1046/j.1469-1809.2005.00162.x
Peters, M. J., Joehanes, R., Pilling, L. C., Schurmann, C., Conneely, K. N., Powell, J.,
et al. (2015). The transcriptional landscape of age in human peripheral blood.
Nat. Commun. 6:8570.
Pooley, K. A., Bojesen, S. E., Weischer, M., Nielsen, S. F., Thompson, D., Amin Al
Olama, A., et al. (2013). A genome-wide association scan (GWAS) for mean
telomere length within the COGS project: identified loci show little association
with hormone-related cancer risk. Hum. Mol. Genet. 22, 5056–5064. doi: 10.
1093/hmg/ddt355
Ransohoff, K. J., Wu, W., Cho, H. G., Chahal, H. C., Lin, Y., Dai, H. J., et al. (2017).
Two-stage genome-wide association study identifies a novel susceptibility locus
associated with melanoma. Oncotarget 8, 17586–17592.
Rode, L., Nordestgaard, B. G., and Bojesen, S. E. (2015). Peripheral blood leukocyte
telomere length and mortality among 64,637 individuals from the general
population. J. Natl. Cancer Inst. 107:djv074.
Samani, N. J., Burton, P., Mangino, M., Ball, S. G., Balmforth, A. J., Barrett,
J., et al. (2005). A genomewide linkage study of 1,933 families affected
Frontiers in Genetics | www.frontiersin.org 11 April 2020 | Volume 11 | Article 337
fgene-11-00337 April 29, 2020 Time: 18:31 # 12
van der Spek et al. Exome-Wide Association Study of Telomere Length
by premature coronary artery disease: the british heart foundation (BHF)
family heart study. Am. J. Hum. Genet. 77, 1011–1020. doi: 10.1086/
498653
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer,
B., et al. (2007). Genomewide association analysis of coronary artery disease.
N. Engl. J. Med. 357, 443–453.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., et al. (1995).
A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science
268, 1749–1753. doi: 10.1126/science.7792600
Scelo, G., Purdue, M. P., Brown, K. M., Johansson, M., Wang, Z., Eckel-Passow,
J. E., et al. (2017). Genome-wide association study identifies multiple risk loci
for renal cell carcinoma. Nat. Commun. 8:15724.
Slagboom, P. E., Droog, S., and Boomsma, D. I. (1994). Genetic determination of
telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet.
55, 876–882.
Strandberg, T. E., Saijonmaa, O., Tilvis, R. S., Pitkala, K. H., Strandberg, A. Y.,
Miettinen, T. A., et al. (2011). Association of telomere length in older men with
mortality and midlife body mass index and smoking. J. Gerontol. A Biol. Sci.
Med. Sci. 66, 815–820. doi: 10.1093/gerona/glr064
Tong, A. S., Stern, J. L., Sfeir, A., Kartawinata, M., De Lange, T., Zhu, X. D., et al.
(2015). ATM and ATR signaling regulate the recruitment of human telomerase
to telomeres. Cell Rep. 13, 1633–1646. doi: 10.1016/j.celrep.2015.10.041
van Rooij, J. G. J., Jhamai, M., Arp, P. P., Nouwens, S. C. A., Verkerk, M., Hofman,
A., et al. (2017). Population-specific genetic variation in large sequencing data
sets: why more data is still better. Eur. J. Hum. Genet. 25, 1173–1175. doi:
10.1038/ejhg.2017.110
Vasa-Nicotera, M., Brouilette, S., Mangino, M., Thompson, J. R., Braund, P.,
Clemitson, J. R., et al. (2005). Mapping of a major locus that determines
telomere length in humans. Am. J. Hum. Genet. 76, 147–151. doi: 10.1086/
426734
Willeit, P., Willeit, J., Brandstatter, A., Ehrlenbach, S., Mayr, A., Gasperi, A., et al.
(2010a). Cellular aging reflected by leukocyte telomere length predicts advanced
atherosclerosis and cardiovascular disease risk. Arterioscler. Thromb. Vasc. Biol.
30, 1649–1656. doi: 10.1161/atvbaha.110.205492
Willeit, P., Willeit, J., Kloss-Brandstatter, A., Kronenberg, F., and Kiechl, S. (2011).
Fifteen-year follow-up of association between telomere length and incident
cancer and cancer mortality. JAMA 306, 42–44.
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstatter, A., et al.
(2010b). Telomere length and risk of incident cancer and cancer mortality.
JAMA 304, 69–75.
Willer, C. J., Li, Y., and Abecasis, G. R. (2010). METAL: fast and efficient meta-
analysis of genomewide association scans. Bioinformatics 26, 2190–2191. doi:
10.1093/bioinformatics/btq340
Wilson, W. R., Herbert, K. E., Mistry, Y., Stevens, S. E., Patel, H. R., Hastings, R. A.,
et al. (2008). Blood leucocyte telomere DNA content predicts vascular telomere
DNA content in humans with and without vascular disease. Eur. Heart J. 29,
2689–2694. doi: 10.1093/eurheartj/ehn386
Zhan, X., Hu, Y., Li, B., Abecasis, G. R., and Liu, D. J. (2016). RVTESTS: an efficient
and comprehensive tool for rare variant association analysis using sequence
data. Bioinformatics 32, 1423–1426. doi: 10.1093/bioinformatics/btw079
Zhao, S., and Fernald, R. D. (2005). Comprehensive algorithm for quantitative real-
time polymerase chain reaction. J. Comput. Biol. 12, 1047–1064. doi: 10.1089/
cmb.2005.12.1047
Conflict of Interest: AS is an employee of the company SkylineDx.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2020 van der Spek, Warner, Broer, Nelson, Vojinovic, Ahmad, Arp,
Brouwer, Denniff, van den Hout, van Rooij, Kraaij, van IJcken, Samani, Ikram,
Uitterlinden, Codd, Amin and van Duijn. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Genetics | www.frontiersin.org 12 April 2020 | Volume 11 | Article 337
